FREEMAN NEOSHO HOSPITAL — History
CCN 261331 | 3-year financial timeline | COVID resilience: 82/100
🛡️ Public data only — no PHI permitted on this instance.
$33M
Latest Revenue (FY2022)
+13.5%
Revenue CAGR (3yr)
3.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $26M | $31M | $33M | +5.5% | +13.5% |
| Operating Expenses | $27M | $30M | $32M | +6.8% | +8.2% |
| Operating Margin | -6.4% | 4.5% | 3.3% | -26.2% | +0.0% |
| Net Income | $-2M | $1M | $1M | -22.1% | +0.0% |
| Licensed Beds | 25 | 25 | 25 | +0.0% | +0.0% |
| Total Patient Days | 2,783 | 3,037 | 3,061 | +0.8% | +4.9% |
| Medicare Day % | 39% | 37% | 46% | +23.6% | +7.9% |
| Medicaid Day % | 8% | 8% | 9% | +14.8% | +11.7% |
COVID Impact & Recovery
Resilience Score: 82/100 — Resilient — strong COVID recovery
Revenue recovery from FY2020 to FY2022: +28.9% ($26M → $33M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▼ Declining
vs State Average ()
Revenue Growth
+13.5%
This Hospital
+7.6%
State Avg
Latest Margin
3.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $37M | 8.2% |
| FY2024 (proj) | $40M | 13.1% |
| FY2025 (proj) | $44M | 18.0% |